Market Place
Sourcing Support
Hansoh signs $690M ADC pact with fellow Chinese biotech Biotheus
16 Mar 2024 //
FIERCE PHARMA
Biotheus Expanded Their Partnership with Hansoh Pharma
15 Mar 2024 //
PR NEWSWIRE
GSK enters exclusive license agreement with Hansoh for HS-20093
21 Dec 2023 //
PRESS RELEASE
GSK enters exclusive license agreement with Hansoh for HS-20089
21 Oct 2023 //
PRESS RELEASE
Antengene, Hansoh Pharma enter partnership to commercialize Xpovio
12 Aug 2023 //
PHARMABIZ
Ameile Patent From Hansoh Pharma Wins China Patent Gold Award
29 Jul 2023 //
PRESS RELEASE
Hansoh & SCYNEXIS Announce NMPA Acceptance of the NDA for Ibrexafungerp
21 Jul 2023 //
PRESS RELEASE
Silence Therapeutics Achieves $4M in Research Milestone Payments from Hansoh
11 Jul 2023 //
BUSINESSWIRE
Hansoh Pharma’s Saint Luolai granted approval for marketing
05 Jul 2023 //
PRESS RELEASE
TiumBio and Hansoh Announce Trial Approval of `HS-10518/TU2670`
05 Jul 2023 //
PR NEWSWIRE
KiOmed Pharma and Hansoh Pharma Announce License Agreement for KiOmedinevsOne
26 Sep 2022 //
BUSINESSWIRE
TiumBio inks licensing deal with China`s Hansoh for endometriosis drug
10 Aug 2022 //
KEDGLOBAL
Latest Results from AENEAS Study of Hansoh Pharma`s Ameile
31 May 2022 //
PRNEWSWIRE
NiKang Tx, Hansoh Pharma Announce Strategic Collaboration and License Agreement
03 May 2022 //
BUSINESSWIRE
Jiangsu Hansoh Pharma`s Generic Fulvestrant Receives Approval in the U.S.
10 Feb 2022 //
FDA
Jiangsu Hansoh Pharma`s Generic Pemetrexed Receives Approval in the U.S.
17 Dec 2021 //
FDA
Hansoh, J&J, Brii and more—Fierce Pharma Asia
22 Oct 2021 //
FIERCEPHARMA
Chinese powerhouse continues charge into siRNA with Silence pact
15 Oct 2021 //
FIERCEBIOTECH
Inhibrx shares rise on PhI trial results; Braglia`s Helsinn partners with Fosun
12 Oct 2021 //
ENDPTS
Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration
12 Oct 2021 //
GLOBENEWSWIRE
SCYNEXIS and Hansoh Pharma Announce Licensing Agreement
17 Feb 2021 //
BUSINESSWIRE
Hansoh announces strategic collaboration with EQRx for almonertinib
24 Jul 2020 //
BIOSPECTRUMASIA
Hansoh announces strategic collaboration with EQRx for almonertinib
23 Jul 2020 //
BIOSPECTRUMASIA
Roche drops hep B antiviral as late-stage pipeline `largely on track` despite
23 Jul 2020 //
FIERCE BIOTECH
Hansoh Announces Strategic Collaboration & Licensing Agreement Almonertinib
22 Jul 2020 //
BUSINESSWIRE
Hansoh Pharma & NiKang Therapeutics Enter into a Development Partnership
23 Apr 2020 //
BUSINESSWIRE
Hansoh Pharma & NiKang Therapeutics Enter into a Development Commercialization
23 Apr 2020 //
BUSINESSWIRE
Hansoh Pharma`s Ameile (Almonertinib) Receives Mkt in China EGFR T790M
19 Mar 2020 //
PRNEWSWIRE
Tasly Biopharma pitches long-awaited IPO
24 Jun 2019 //
ENDPTS
Hansoh grabs $1B windfall in the latest China pharma IPO
08 Jun 2019 //
ENDPTS
Big Pharma`s China growth; Pfizer`s new Upjohn HQ; Hansoh`s $1B Hong Kong IPO
31 May 2019 //
FIERCE PHARMA
China`s Hansoh secures GIC, Boyu Capital among investors for up to $1B HK IPO
31 May 2019 //
REUTERS
Hansoh Pharma`s $1 Billion Hong Kong IPO Draws GIC, Boyu Capital
29 May 2019 //
BLOOMBERG
Jiangsu Hansoh Pharm`s Generic Olanzapine Receives Approval in US
28 Sep 2018 //
FDA
Alimta® (Pemetrexed Disodium): Eli Lilly V. Jiangsu Hansoh Pharmaceutical Group
21 Aug 2017 //
PATENT LITIGATION
China`s Simcere seeks return to public market with $1B HKEx IPO
07 Jan 2016 //
FIERCE PHARMA ASIA
China`s Jiangsu Hansoh plans $3B IPO to tap investor demand
06 Jan 2016 //
FIERCE PHARMA ASIA
Chinese Drugmaker Plans up to $3 Billion Hong Kong IPO
05 Jan 2016 //
NASDAQ
Chinese drugmaker Jiangsu Hansoh Pharma plans $1.5 bln HK IPO in 2016-IFR
14 Dec 2015 //
REUTERS
